JP Morgan Chase’s Cellyan Biotechnology HKPD Stock Holding History
Bought
Maintained
Sold
Other funds holding HKPD
JP Morgan Chase's HKPD Position: Q3 2026 in Review
JP Morgan Chase opened a new position in Cellyan Biotechnology (HKPD) in Q3 2026: 6 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #8037 among its holdings.
9 funds tracked by Wall St. Rank hold HKPD as of Q3 2026.
- JP Morgan Chase held 6 shares of Cellyan Biotechnology worth $12 as of Q3 2026.
- Cellyan Biotechnology was a new JP Morgan Chase position in Q3 2026.
- Cellyan Biotechnology made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #8037 holding.
- 9 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.